Dapiprazole Hydrochloride is an alpha-1-adrenergic antagonist that acts by blocking alpha-adrenergic receptors in the smooth muscle of blood vessels (arteries, arterioles and veins), gastrointestinal tract, and radial smooth muscle of the iris. This prevents smooth muscle contraction and results in vasodilatation. Administered in the eye, dapiprazole hydrochloride produces miosis. In the heart, it may antagonize alpha-1 adrenoreceptors in myocytes causing a mild negative inotropic effect. It is grouped under the following drug class(es): Alpha-1 Blockers. Its therapeutic use is listed as ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Glamidolo, Reversil and Remydrial. Its PubChem CID is 6917787.
Dapiprazole hydrochloride
| CAS No | 72822-13-0 |
|---|---|
| Molecular Formula | C19H28ClN5 |
| Molecular Weight | 361.9 g/mol |
| Synonyms | 3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dapiprazole Hydrochloride is an alpha-1-adrenergic antagonist that acts by blocking alpha-adrenergic receptors in the smooth muscle of blood vessels (arteries, arterioles and veins), gastrointestinal tract, and radial smooth muscle of the iris.
The listed CAS number is 72822-13-0.
The listed molecular formula is C19H28ClN5.
The listed molecular weight is 361.9 g/mol.
3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;hydrochloride.
The source lists Glamidolo, Reversil and Remydrial.